Chronic challenges to healthcare policy
There were several news stories this week worth commenting on here. Each involved the relationship between medicines and the chronically ill, and each served to highlight the fact that conventional allopathic, Big Pharma-created and FDA-approved “drugs” are not getting the job done – at least not to the satisfaction of those who most need the relief they promise. The implications of this may range much further than that segment of our society.
The first was a Reuters piece on how dietary supplements are being used by our society; as it turns out, their most common use is among those with chronic disease, who’ve apparently discovered they get at least as much benefit from naturopathy as from more accepted methods. According to the article, “Having one or more chronic illness [sic] is the primary factor associated with the use of dietary supplements. Cancer survivors also use supplements to treat chronic medical conditions … a new study shows.”
Of course, after these two introductory sentences, the Reuters story goes immediately into dutiful obeisance to the conventional idols of regulation and orthodoxy, quoting a National Cancer Institute representative (who led the study) on her concerns about the “dangers” of permitting such free choices on the part of patients. As Dr. Melissa Farmer Miller reportedly puts it, “We really are just beginning to build an evidence base on the benefits of dietary supplements.” She then adds the kicker: “Even if there’s not a benefit, there is a potential for them to cause harm.” In other words, the assumption is of the negative effects of these supplements, rather than of their possible value – in spite of the obvious market evidence of their widespread use by the chronically ill.
Read the rest of this entry »
